Esophageal Carcinoma

Esophageal carcinoma ranks among aggressive GI malignancies, primarily adenocarcinoma (lower esophagus, GERD-linked) and squamous cell carcinoma (upper/mid, smoking/alcohol-related). In NCR regions like Faridabad, rising incidence ties to lifestyle factors, demanding vigilant screening.

Symptoms

Progressive dysphagia—initially solids, then liquids—signals obstruction, alongside unintentional weight loss, odynophagia, chest pain mimicking heartburn, hoarseness, chronic cough, or hemoptysis. Advanced cases bring fatigue, anemia, or metastases-related bone pain. NCR patients often delay seeking care until advanced.

Causes and Risk Factors

Chronic GERD with Barrett's esophagus fuels adenocarcinoma; tobacco, alcohol, hot beverages, and poor diet drive squamous type. Obesity, HPV, and achalasia heighten risks. Faridabad urban diets amplify preventable factors.

Diagnosis and Treatment

Endoscopy with biopsy confirms; CT/PET stages spread. Early stages favor surgery (esophagectomy); neoadjuvant chemoradiation shrinks locally advanced tumors. Stage IV relies on chemotherapy, immunotherapy (PD-1 inhibitors), and stents for palliation. NCR oncology hubs integrate multidisciplinary protocols.

Prevention Strategies

Quit smoking/alcohol; manage GERD; maintain BMI; endoscopic surveillance for high-risk cases.